No Proven Links Between Eczema Drug, Cancer: Judge

Law360, New York (July 9, 2008, 12:00 AM EDT) -- A judge has granted summary judgment in favor of Novartis Pharmaceuticals Corp. in a suit that alleged the company's eczema drug Elidel causes lymphoma.

Judge Stewart Dalzell of the U.S. District Court for the Eastern District of Pennsylvania granted summary judgment Wednesday on the grounds that the plaintiffs' expert testimony was inadmissible because those experts failed to produce compelling evidence linking the drug's active ingredient, pimecrolimus, with the cancer.

The judge found “an analytical gap” between the data the two expert scientists produced “and the specific...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.